FDA Import Refusal 799-5462983-3/1/1 — Boehringer Ingelheim Canada
The FDA refused shipment 799-5462983-3/1/1 from Boehringer Ingelheim Canada (Canada) on May 18, 2016. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 18, 2016
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61LCE41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
- Charges
- 75